David MacPherson

15PUBLICATIONS
115CO-AUTHORS
Molecular targetsChemotherapyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 22, 2026
CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer.

|Jul 07, 2026
Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.

|Apr 29, 2025
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.

Ling Cai, Fangjiang Wu, Qinbo Zhou

|Apr 25, 2025
MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues.

Brian Freie, Ali H Ibrahim, Patrick A Carroll

|Apr 23, 2025
In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer.

Lauren Brumage, Scott Best, Daniel S Hippe

|Oct 10, 2024
MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues.

Brian Freie, Ali H Ibrahim, Patrick A Carroll

Pageof 3

Frequent Collaborators

4 joint publications

Charles M Rudin

3 joint publications

Ali H Ibrahim

3 joint publications

Gavin Ha

3 joint publications

Anna-Lisa Doebley